Document
IPR2017-00195, No. 1041-40 Exhibit - Avonex Product Label 2006 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00195, No. 1041-40 Exhibit - Avonex Product Label 2006 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00195, No. 1017-16 Exhibit - Yedas Preliminary Patent Owner Response, IPR2015 00643 Paper No 11 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00195, No. 1017-16 Exhibit - Yedas Preliminary Patent Owner Response, IPR2015 00643 Paper No 11 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00195, No. 1064-63 Exhibit - Schrempf (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00195, No. 1064-63 Exhibit - Schrempf (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00195, No. 1036-35 Exhibit - Haines (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00195, No. 1036-35 Exhibit - Haines (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00195, No. 1003-67 Exhibit - Declaration of Dr Ari Green (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00195, No. 1003-67 Exhibit - Declaration of Dr Ari Green (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00195, No. 1032-31 Exhibit - Copaxone Product Label Feb 2009 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00195, No. 1032-31 Exhibit - Copaxone Product Label Feb 2009 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00195, No. 1014-13 Exhibit - Decision, Institution of Inter Partes Review, IPR2015 00643 Paper No 13 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00195, No. 1014-13 Exhibit - Decision, Institution of Inter Partes Review, IPR2015 00643 Paper No 13 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00195, No. 1027-26 Exhibit - FDA Meeting Agenda Minutes (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00195, No. 1027-26 Exhibit - FDA Meeting Agenda Minutes (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
PGR2016-00010, No. 2013 Exhibit - Cobert, et al, Practical Drug Safety from A to Z, Jones and Bartlett Publishers, 2009, pp 327 329 (P.T.A.B. May. 24, 2016)
Cite Document
PGR2016-00010, No. 2013 Exhibit - Cobert, et al, Practical Drug Safety from A to Z, Jones and Bartlett Publishers, 2009, pp 327 329 (P.T.A.B. May. 24, 2016)
+ More Snippets
Document
PGR2016-00010, No. 2004 Exhibit - US Application No 13770,677 (P.T.A.B. May. 24, 2016)
Cite Document
PGR2016-00010, No. 2004 Exhibit - US Application No 13770,677 (P.T.A.B. May. 24, 2016)
+ More Snippets
Document
PGR2016-00010, No. 2014 Exhibit - World Health Organization, A Practical Handbook on the Pharmacovigilance of Antiretroviral Medicines, 2009, 129 133 (P.T.A.B. May. 24, 2016)
Cite Document
PGR2016-00010, No. 2014 Exhibit - World Health Organization, A Practical Handbook on the Pharmacovigilance of Antiretroviral Medicines, 2009, 129 133 (P.T.A.B. May. 24, 2016)
+ More Snippets
Document
PGR2016-00010, No. 2010 Exhibit - Reuters Press Release, New Data Presented at the 28th ECTRIMS Congress Showcase Tevas Ongoing Commitment to Multiple Sclerosis Research, Octobe...
Cite Document
PGR2016-00010, No. 2010 Exhibit - Reuters Press Release, New Data Presented at the 28th ECTRIMS Congress Showcase Tevas Ongoing Commitment to Multiple Sclerosis Research, October 8, 2012 (P.T.A.B. May
+ More Snippets
Document
PGR2016-00010, No. 2006 Exhibit - US Application No 12806,684 (P.T.A.B. May. 24, 2016)
Cite Document
PGR2016-00010, No. 2006 Exhibit - US Application No 12806,684 (P.T.A.B. May. 24, 2016)
+ More Snippets
Document
PGR2016-00010, No. 2011 Exhibit - A phase 3 trial to assess the efficacy and safety of glatiramer acetate injections 40 mg administered 3 times a week compared to placebo, Abstract 166, Multi...
Cite Document
PGR2016-00010, No. 2011 Exhibit - A phase 3 trial to assess the efficacy and safety of glatiramer acetate injections 40 mg administered 3 times a week compared to placebo, Abstract 166, Multiple Scler
+ More Snippets
Document
PGR2016-00010, No. 2012 Exhibit - US Application No 14630,326 (P.T.A.B. May. 24, 2016)
Cite Document
PGR2016-00010, No. 2012 Exhibit - US Application No 14630,326 (P.T.A.B. May. 24, 2016)
+ More Snippets